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ABSTRACT
Study design: a descriptive, prospective cohort study. Objectives: identify the risk factors associated with SAPS 3 and 
APACHE II score to improve mortality prediction in elderly admitted in the intensive care unit (ICU).  Methodology: 
a cohort study with 174 elderly patients admitted in ICU from July 2016 to June 2017. The primary independent vari-
ables analyzed were: presence of stress hyperglycemia, the need for invasive mechanical ventilation (IMV), acute re-
nal failure, level of consciousness and use of vasopressors. The outcomes studied were death and hospital discharge. 
Results: ICU and hospital mortality were 17.8% and 29.8%, respectively. The multivariate analysis of factors associated 
with hospital death not contemplated in the obtaining of SAPS 3 demonstrated that IMV, Chronic Obstructive Pulmonary Dis-
ease (COPD) and Mean Arterial Pressure (MAP) <70 mmHg improved the prediction of mortality. The Hosmer-Lemeshow test 
(p=0.472) and area under ROC curve=0.80 (CI95%:0.731-0.872) confirmed, respectively, an appropriate calibration and 
acceptable-to-excellent discriminatory power for this model. IMV and COPD were also factors associated with the APACHE 
II score in prediction of mortality with appropriated calibration (p=0.471) and acceptable-to-excellent discriminatory power 
(area under ROC curve=0.80 [CI95%:0.730-0.868]). Conclusion: IMV, COPD, and MAP <70 mmHg were associated with 
SAPS3 and APACHE II to predict mortality in elderly admitted to ICU.
Keywords: Prognostic Factors; Mortality; Elderly; Intensive Care Unit; SAPS 3; APACHE II.
RESUMO 
Modelo de estudo: estudo descritivo, coorte prospectiva. Objetivos: identificar os fatores de risco associados ao escore 
SAPS 3 e APACHE II para melhorar a predição de mortalidade em idosos internados em unidade de terapia intensiva (UTI). 
Metodologia: estudo de coorte com 174 idosos internados em UTI no período de julho de 2016 a junho de 2017. As princi-
pais variáveis  independentes analisadas foram: presença de hiperglicemia de estresse, necessidade de ventilação mecânica 
invasiva (VMI), insuficiência renal aguda, nível de consciência e uso de vasopressores. Os desfechos estudados foram morte 
e alta hospitalar. Resultados: A mortalidade na UTI e hospitalar foi de 17,8% e 29,8%, respectivamente. A análise multiva-
riada de fatores associados à morte hospitalar não contemplada na obtenção do SAPS 3 demonstrou que a VMI, Doença Pul-
monar Obstrutiva Crônica (DPOC) e Pressão Arterial Média (PAM) <70 mmHg melhoraram a predição de mortalidade. O teste 
de Hosmer-Lemeshow (p = 0,472) e a área sob curva ROC = 0,80 (IC95%: 0,731-0,872) confirmaram, respectivamente, 
calibração adequada e poder discriminatório aceitável a excelente para este modelo. VMI e DPOC também foram fatores 
associados ao escore APACHE II na predição de mortalidade com calibração adequada (p = 0,471) e poder discriminatório 
aceitável-a-excelente (área sob curva ROC = 0,80 [IC95%: 0,730-0,868]). Conclusão: VMI, DPOC e PAM <70 mmHg foram 
associados ao SAPS3 e ao APACHE II para predizer mortalidade em idosos internados em UTI.
Palavras-chave: Fatores Prognósticos; Mortalidade; Idosos; Unidade de Terapia Intensiva; SAPS 3; APACHE II.
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BACKGROUND
Admission to the Intensive Care Unit 
(ICU) is associated with high mortality and 
contributes to higher one-year mortality rates 
after discharge1. Elderly patients are respon-
sible for approximately 42-50% of the admis-
sions and about 60% of ICU stays2. Clinical 
outcomes in intensive care are measured using 
scores that frequently consider the severity of 
baseline comorbidities3. The Acute Physiology 
and Chronic Health Evaluation II (APACHE II)4 
and the Simplified Acute Physiology Score 3 
(SAPS 3)5 scores are widely used in clinical prac-
tice to calculate the individual’s prognosis as well 
as to guide therapeutic decisions in ICU patients.
Some independent predictors of death in 
elderly patients admitted in ICU were previously 
described in literature: stress hyperglycemia, 
need for invasive mechanical ventilation (IMV), 
multiple organs dysfunctions, altered level of 
consciousness, septic shock, need for vasoactive 
agents, chronic obstructive pulmonary disease 
(COPD), and mean arterial pressure (MAP) below 
70mmHg6-11. However, the SAPS 3 and APACHE 
II scores do not consider some of the risk fac-
tors already described to affect independently the 
mortality rates, which might underestimate their 
predictive values.
This study aimed to recognize risk factors 
that might be associated with the SAPS 3 and 
APACHE II to improve the prediction of hospital 
mortality of elderly patients admitted to ICU. 
MATERIALS AND METHODS
The present study was a prospective cohort 
study conducted between July 2016 and June 2017 
on patients admitted to a public regional ICU in 
Recife, Pernambuco.
Population
Patients of both sexes aged 60 or more 
years admitted and stayed in the ICU for more 
than 24 hours were eligible for inclusion.
Patients were excluded if diagnosed with 
terminal cancer under palliative care. Multiple ICU 
readmissions within a single hospital stay were 
considered as one single admission.
All patients received standard medical treat-
ment under the direction of the consultant physician.
The primary outcome measures were death 
or hospital discharge.
Data acquisition
All data were collected concurrently for 
consecutive ICU admissions. A structured ques-
tionnaire was used to extract data from medical 
records and guide the history taking of a patient 
or the family.
Data included sociodemographic informa-
tion, age, sex, past medical conditions (such as 
hypertension, diabetes, COPD, chronic kidney 
or hepatic disease) and lifestyle habits (such as 
alcohol intake and smoking). The APACHE II and 
SAPS 3 scores were calculated following the origi-
nal methodology, using the worst physiologic val-
ues in the first ICU day and the first two hours 
after admission, respectively.
Regarding the Glasgow Coma Scale (GCS), 
the best results were adopted to define the level 
of consciousness. Multiple organs failure was 
defined according to the criteria of Knaus et al4.
All patients were followed until discharge 
from the hospital or death.
Operational definitions
Stress hyperglycemia was defined as capil-
lary blood glucose > 180 mg/dL15. Capillary blood 
glucose was performed using the first drop of 
blood obtained thought finger puncture with dis-
posable lancets. A measurement was performed 
every four hours and the higher value in the first 
24 hours was chosen.
Acute Kidney Injury (AKI) was defined fol-
lowing the Acute Kidney Injury Network (AKIN) 
classification: absolute increase within 48 hours 
in serum creatinine ≥ 0.3 mg/dL; a percentage 
increase in serum creatinine ≥ 50% or 1.4-fold 
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from the baseline; or documented oliguria of 
< 0.5 ml/kg/h for at least 6 hours16. Creatinine 
blood samples were processed using the Beckman 
Coulter AU automated method.
Altered level of consciousness was defined 
as 8 points or less in the GCS17 in absence of sed-
ative drugs and orotracheal tube.
COPD was defined as the presence of a 
post-bronchodilator forced expiratory volume in 
one second (FEV1) < 80% of the predicted value 
in combination with a FEV1/forced vital capac-
ity (FVC) < 70% in a spirometry test or self-re-
ported physician’s diagnosis of chronic bronchi-
tis, emphysema, or COPD, associated within use 
of long-acting muscarinic antagonist (LAMA) and 
long-acting beta-agonist (LABA) or inhaled corti-
costeroids18.
Intermittent non-invasive blood pressure 
monitoring was used to acquire diastolic blood 
pressure (DBP) and systolic blood pressure (SBP). 
Mean arterial pressure (MAP) was calculated by 
the formula (2xDBP + SBP)/3. 
Statistical analysis
The sample size was calculated based on 
the purpose of identifying at least five predic-
tors of death. For multiple regression models of 
dichotomous variables, at least ten outcomes for 
each predictor might be needed to compound the 
model with statistical precision12. In a model with 
five dichotomous predictors, as planned for this 
study, at least 50 outcomes are needed. Expect-
ing a mortality rate of 30%13,14, the minimum 
sample size is 167 individuals.
We considered for the statistical analyses 
that the SAPS 3 and APACHE II scores are corre-
lated (Pearson test: r = 0.83; p < 0.001). Inde-
pendent analyses were performed to determine 
which factors might be associated with the scores 
to improve the prediction of hospital death. The 
relationship between hospital death and each 
potential factor associated with the SAPS 3 and 
APACHE II was determined and adjusted using 
simple logistic regression models. According to 
the recommendations of Hosmer-Lemeshow19, the 
factors with a significance level of p < 0.25 were 
selected and included in a multivariate logistic 
regression model. The results were adjusted for 
two models: one to investigate factors associated 
with the SAPS 3 and another to examine factors 
associated with the APACHE II. The selection of 
factors for each model was performed employing 
the backward stepwise method, adopting a sig-
nificance level of 5%. For each adjusted model, 
the goodness of fit was evaluated using the Hos-
mer-Lemeshow and the discriminatory power was 
evaluated using the area under the ROC curve. 
The Stata 12.1SE software (StataCorp, 4905 
Lakeway Drive, College Station, Texas 77845 
USA) was used to process the statistical analyses.
Ethical standards
The study protocol was previously approved 
by the Institutional Ethics Committee (CAAE: 
31993814.6.0000.5208) and respected the Res-
olution 196/96 of the Brazilian National Health 
Council, which deals with the guidelines and 
standards for research involving humans. The 
investigation was also carried out in accordance 
with the Declaration of Helsinki. Informed con-
sent was obtained from all patients prior to the 
inclusion in this study.
RESULTS
A total of 174 patients was eligible for the 
study (Figure 1). Mean age was 71.5 years. The 
ICU and hospital mortality rates were 17.8% and 
29.8%, respectively. The mean of the APACHE II 
and SAPS 3 scores were 19.1 (16.7 among dis-
charged patients and 24.9 among those in which 
the outcome was death) and 43.6 (38.7 among 
discharged patients and 55.0 among those in 
which the outcome was death), respectively. The 
mean length of ICU and hospital stay were 7.2 and 
32 days, respectively. Population characteristics 
and prevalence of outcomes are shown in Table 1.
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Table 1 (Continuation)
(continue...) (continue...)
587 admited
Age < 60 years:
285 patients
Admission < 24h:
83 patients
Readmitted:
44 patients
302 elderly
Terminal: 1 patient
122 discharges
174 included
52 deaths
21 in infirmary
31 in ICU
Figure 1: Diagram of inclusion and follow up of the popula-
tion studied. 
Table 1 
Summary of sociodemographic, clinical, and laboratorial 
data of the study population.
Variable
Sample Outcome: death
N N (%)
Gender
Male 79 25 (31.6%)
Female 95 30 (31.5%)
Ethnicity
White 85 23 (27.1%)
Non-White 89 32 (35.9%)
Marital Status
Single 22 5 (22.7%)
Married 87 24 (27.5%)
Widowed 52 7 (13.4%)
Divorced 13 6 (46.1%)
Years of study
0 36 12 (50.0%)
1-4 79 27 (34.1%)
5-8 34 10 (29.4%)
9-11 18 4 (22.3%)
12-16 1 0 (0.0%)
≥ 17 6 1 (16.7%)
Organic system affected
Neuro 13 6 (46.1%)
Cardio 82 16 (19.5%
Variable
Sample Outcome: death
N N (%)
Pneumo 32 13 (40.6%)
Gastro 25 11 (44%)
Nefro/Metab 20 9 (45%)
Reason of admission
High-risk post-op 62 11 (17.7%)
ARF 25 9 (36%)
ALC 13 7 (53.8%)
Shock 15 9 (60%)
ACS 16 1 (6.2%)
Arrhythmias 4 2 (50%)
Other 23 8 (34.7%)
IMV 74 41 (55.4%)
Length of IMV (days) 5.9 ± 5.5 8.1 ± 8.5
TQT 15 9 (60%)
Length of TQT (days) 47 ± 50.3 31.2 ± 22.5
Hypertension 139 40 (28.7%)
DM 87 25 (28.7%)
COPD  7 4 (57.1%)
Smoking 36 10 (27.7%)
Alcoholism 19 6 (31.5%)
Chronic Hepatic Disease 8 5 (62.5%)
Kidney Injury
Acute 45 25 (55.5%)
Chronic 31 13 (41.9%)
Cancer 25 8 (32%)
Infection 77 34 (44.1%)
Vasoactive agent 79 35 (44.3%)
MAP (mmHg)
< 70 31 23 (74.1%)
70-109 66 14 (21.2%)
≥ 110 77 18 (23.3%)
Respiratory rate
< 12 1 0 (0%)
12-24 110 30 (27.2%)
≥ 25 63 25 (39.6%)
Cardiac rate
< 120 146 43 (29.4%)
120-159 27 12 (44.4%)
≥ 160 1 0 (0%)
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Table 1 (Continuation)
Variable
Sample Outcome: death
N N (%)
Temperature (º C)
< 34,5 50 19 (38%)
≥ 34,5 124 36 (29.1%)
Hematocrit (%)
< 30 87 34 (39.1%)
30-45 84 19 (22.6%)
≥ 46 3 2 (66.6%)
Platelets (in thousands)
< 20 2 2 (100%)
20-49 3 1 (33.3%)
50-99 17 8 (47.1%)
Total Bilirubin (md/dL)
≥ 100 152 44 (28.9%)
< 2 159 45 (28.3%)
2-5.9 10 7 (70%)
≥ 6 5 3 (60%)
Leucocytes
< 15,000 112 31 (27.6%)
≥ 15,000 62 24 (38.7%)
pH
≤ 7,25 29 16 (55.1%)
> 7,25 145 39 (26.8%)
ARF = acute respiratory failure; ALC = altered level of consciousness; 
ACS = acute coronary syndrome. IMV = invasive mechanical ventila-
tion; TQT = tracheostomy; DM = diabetes mellitus; COPD = chronic 
obstructive pulmonary disease; MAP = mean arterial pressure.
According to the multivariate analy-
ses (Table 2), IMV, OCPD and MAP < 70 mmHg 
were associated with the SAPS 3 to predict hos-
pital mortality. The Hosmer-Lemeshow test 
(p = 0.472) and the area under ROC curve (0.80 
[CI95%:0.731-0.872]). Figure 2 confirms appropri-
ate calibration and acceptable discriminatory power 
for the model composed of those four variables.
The results of the univariate and multivar-
iate analyses of factors associated with hospital 
death not included in the APACHE II score are 
shown in Table 2. According to the multivariate 
analyses IMV and OCPD were associated with 
the APACHE II to predict hospital mortality. The 
Hosmer-Lemeshow test (p = 0.471) and the area 
under ROC curve (0.80 [CI95%:0.730-0.868]). 
ROC Curve
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Source of the
Curve
SAPS 3
Modified SAPS 3 
Reference Line
1,0
0,8
0,6
0,4
0,2
0,0
0,0 0,2 0,4 0,6 0,8 1,0
Figure 2: Receiver Operating Characteristics (ROC) curve 
for SAPS3.
Blue line - ROC curve for isolated SAPS 3 score (AUC 0.77 
[CI95%: 0.706-0.852]). Green line – ROC curve for the modified 
SAPS 3 score including COPD, IMV, and MAP < 70 mmHg (AUC 
0.80 [CI95%:0.731-0.872]).
ROC Curve
Se
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ty
Source of the
Curve
APACHE II
Modified APACHE II
Reference Line
1,0
0,8
0,6
0,4
0,2
0,0
0,0 0,2 0,4 0,6 0,8 1,0
1 - Specificity
Figure 3: Receiver Operating Characteristics (ROC) curve 
for APACHE II.
Blue line - ROC curve for isolated APACHE II score (AUC 0.78 
[CI95%: 0.718-0.857]). Green line – ROC curve for the mo-
dified APACHE II score including COPD, and IMV (AUC 0.80 
[CI95%:0.730-0.868]).
Figure 3 confirms appropriate calibration and 
acceptable discriminatory power for the model 
composed of those three variables.
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Table 2 
Univariate analyses and final model of factors associated with hospital death not included in the SAPS 3 and APACHE II.
Variable
Univariate model Multivariate model
OR (CI 95%) p-value OR (CI 95%) p-value
IMV 6.48 (3.14-13.40) <0.001 3.83 (1.49-9.83) 0.005
Length of IMV 1.13 (1.06-1.21) <0.001 - -
TQT 2.99 (1.02-8.73) 0.047 - -
Length of TQT 1.01 (0.99-1.03) 0.570 - -
COPD 3.31 (0.71-15.33) 0.126 6.82 (1.22-38.18) 0.029
Hypertension 0.48 (0.22-1.04) 0.067 - -
DM 0.80 (0.42-1.54) 0.508 - -
Smoking 0.88 (0.39-1.99) 0.755 - -
Alcoholism 0.82 (0.28-2.41) 0.716 - -
Hepatic Failure 4.22 (0.97-18.36) 0.051 - -
AKI 3.16 (1.55-6.44) 0.002 - -
Hyperglycemia 0.77 (0.40-1.49) 0.439 - -
Vasoactive agents 2.55 (1.31-4.98) 0.005 - -
MAP < 70 mmHg 3.45 (1.66-7.19) <0.001 2.78 (1.15-6.74) 0.023
RF < 25 0.55 (0.28-1.07) 0.077
Na
<130 mEg/l 1.26 (0.50-3.17)
0.057 - -130-149 mEq/l 1.0 (reference)
≥150 mEq/l 5.37 (1.28-22.55)
K -
<3.5 mEq/l 1.00 (0.42-2.39)
0.999 - -3.5-5.4 mEq/l 1.0 (reference)
≥ 5.5 mEq/l 0.98 (0.32-2.96)
Ht < 30% 1.95 (1.00-2.78) 0.046 - -
Platelets < 100 000 2.18 (0.88 - 5.43) 0.098
Total Bilirubin < 2 mg/dL 0.25 (0.08 - 0.74) 0.011 - -
GCS ≤ 8 2.77 (1.33-5.77) 0.007 - -
ICU stay length 1.06 (1.01-1.10) 0.008 - -
SAPS 3 - - 1.03 (1.00-1.06) 0.027
APACHE II - - 1.08 (1.02-1.14) 0.027
IMV = invasive mechanical ventilation; TQT = tracheostomy; COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus; 
MAP = mean arterial pressure; AKI = acute kidney injury; GCS = Glasgow coma scale; RF = respiratory frequency; Na = serum sodium;  
K = serum potassium; Ht = hematocrit. † stress hyperglycemia.
DISCUSSION
Our findings suggest that the need for IMV, 
history of COPD and MAP below 70 mmHg are 
important prognostic factors associated with hos-
pital death in elderly patients admitted to ICU.
The SAPS 3 was associated with the need 
for IMV, history of COPD and MAP below 70 mmHg 
demonstrated an improved predictive power in 
comparison with the data originally described in 
this score. This tendency was also verified for the 
association between APACHE II, the need for IMV 
and a history of COPD. There were no differences 
in the predictive power of these two models.
The need for IMV was independently asso-
ciated with hospital mortality. These results are in 
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accordance with previous findings13,20. Farfel et al. 
did not consider age as a factor associated with 
hospital mortality in the elderly with no need for 
IMV21. Silva et al. found that patients older than 
65 years in the use of IMV presented a poor prog-
nosis and reported a mortality rate three times 
higher in ICU, higher length of need for IMV and 
lower rates of extubating compared to younger 
patients with similar clinical conditions22. Mortal-
ity rates two years after ICU discharge in subjects 
aged 80 or more years with a history of  need for 
IMV were higher in  those with acute illness (78%), 
admitted because of surgical urgencies (46%) 
and elective admissions (35%)22.
According to our results, COPD is also asso-
ciated with hospital death in elderly individuals. 
This finding is in accordance with those reported 
by Teixeira et al. They observed that patients with 
history of COPD had a high mortality rate in ICU 
(27%) and two years after hospital discharge 
(68%)24. Ongel et al. recommend that cases with 
severe COPD and cardiac comorbidities might 
be carefully monitored in intensive care settings 
because of the elevated risk of mortality25.
Some recent studies reported that stress 
hyperglycemia was associated with worse out-
comes in adults26 and elderly13,27 patients admit-
ted to ICU. Despite that, our study did not assure 
this association. Gale et al 28 described that the 
aggressive glycemic control in patients with 
stress hyperglycemia is associated with increased 
mortality. In our study, the correction of glycemic 
levels was not evaluated which might partially 
justify the absence of the association described 
in literature.
The association between AKI and ICU mor-
tality is controversial. Some studies recognized a 
relationship between  increased length of stay in 
ICU, mortality and AKI29. It also seems to predict 
hospital readmission in individuals discharged of 
ICU and is associated with a higher probability 
of death 30 days after discharge30. Nevertheless, 
other studies demonstrated that AKI is not asso-
ciated with mortality in subjects admitted in ICU 
and higher creatinine levels are associated with 
lower mortality rates in hemodialytic patients31,32. 
This study did not observe any associations 
between mortality and AKI. It is plausible that 
the wide variability of criteria adopted to define 
AKI is responsible for those divergences among 
the studies.
We were also unsuccessful to establish any 
relationship between need for vasoactive agents, 
level of consciousness, and mortality. According 
to the literature, vasoactive agents might predict 
mortality in patients aged 90 years or more27.
Limitations
Our study presented some limitations: It 
was performed just in one center, based on a con-
venience sample, standard treatment was defined 
according to the on-call physician’s discretion. 
Also, some important variables were not possible 
to be included in the final model, such as oxygen-
ation index (PaO2/FiO2 ratio) and drugs in use.
The study included high-risk post-op 
patients, which corresponded to 35.5% of the 
sample. Surgical patients tend to present higher 
rates of unfavorable outcomes, which may have 
played some influence in our results.
In the ICU where this study was performed, 
the mortality rate is under the regional mean, in 
some cases up to 50% lower.
CONCLUSION
The past of COPD, need for IMV during the 
admission and MAP < 70mmHg are associated 
with the APACHE II and SAPS3 scores to predict 
mortality in the elderly patients admitted in ICU.
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